Supporting Statement B

SSB ACE Invstg Flint Rash Drmtlgy Fllw-up.docx

Assessment of Chemical Exposures (ACE) Investigations - FY2016 Q2 Burden Report

Supporting Statement B

OMB: 0923-0051

Document [docx]
Download: docx | pdf

REQUEST FOR APPROVAL UNDER THE GENERIC CLEARANCE

OF ASSESSMENT OF CHEMICAL EXPOSURES (ACE) INVESTIGATIONS DATA COLLECTIONS (0923-0051)



(Part B: Collections of Information Employing Statistical Methods)



April 2016





















Point of Contact:

Mary Anne Duncan, DVM, MPH

Epidemiologist, Surveillance Team

Environmental Health Surveillance Branch

Division of Toxicology and Human Health Sciences

Agency for Toxic Substances and Disease Registry

4770 Buford Hwy NE, MS F-58

Atlanta, GA 30341

Phone: 770-488-3668

Email: [email protected]

Table of Contents


B. Collections of Information Employing Statistical Methods

1. Respondent Universe and Sampling Method

2. Procedures for the Collection of Information

3. Methods to Maximize Response Rates and Deal with Nonresponse

4. Tests of Procedures or Methods to be Undertaken

5. Individuals Consulted on Statistical Aspects and Individuals Collecting and/or Analyzing Data


Attachments

  1. Flint Rash Dermatology Follow-up State Request

  2. Flint Rash Dermatology Follow-up Report Form

  3. Flint Rash Dermatology Follow-up Research Determination




REQUEST FOR APPROVAL UNDER THE GENERIC CLEARANCE

OF ASSESSMENT OF CHEMICAL EXPOSURES (ACE) INVESTIGATIONS DATA COLLECTIONS (0923-0051)

TITLE OF INFORMATION COLLECTION: Flint Rash Dermatology Follow-up

Shape1

B. Collections of Information Employing Statistical Methods



1. Respondent Universe and Sampling Methods


Participants in the Flint Rash Investigation survey who later were examined at one of the free dermatology clinics arranged by Michigan Department of Health and Human Services (MDHHS) and local dermatologists are the respondent universe.


2. Procedures for the Collection of Information


Persons seen at one of the free dermatology clinics offered by local dermatologists will be contacted by telephone and asked questions to determine if the dermatology screening process is working, including transitioning of care to the participants' primary care physicians, ensuring that records have been received and results communicated clearly, and identifying any further need for assistance. Any gaps identified will result in notification of staff who will work to fill those gaps immediately.


3. Methods to Maximize Response Rates and Deal with Nonresponse


Participation is completely voluntary. Multiple telephone calls will be made in an attempt to reach potential participants.



4. Tests of Procedures or Methods to be Undertaken


Because the target population has been contacted by telephone within the past two months, the team should have current contact information.


5. Individuals Consulted on Statistical Aspects and Individuals Collecting and/or Analyzing Data


Investigators will collaborate extensively with health officials at MDHHS throughout the process of data collection. The follow-up will be supervised by an MDHHS medical epidemiologist, with assistance as needed from CDC/ATSDR epidemiologists.

Information gathered will be used to facilitate further service to the participant who has provided the information. Any report of the information collected will be contain basic summary statistics such as counts and frequencies. If needed, statistical resources are available at both ATSDR and CDC.



File Typeapplication/vnd.openxmlformats-officedocument.wordprocessingml.document
AuthorMary Anne Duncan
File Modified0000-00-00
File Created2021-01-23

© 2024 OMB.report | Privacy Policy